Certain Shares of Formycon AG are subject to a Lock-Up Agreement Ending on 2-AUG-2023.
Details:
Following the private placement, Formycon will be subject to a lock-up obligation with market-standard exemptions for a period of six months.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.65 EUR | +0.12% | +4.03% | -24.47% |
Apr. 25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
1st Jan change | Capi. | |
---|---|---|
-24.47% | 809M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |